Patent · US Active

Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith

US9879028B2 · kind B2 · utility

10Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 11, 2013
Grant dateJan 30, 2018
Priority date—
Expiry dateSep 11, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided are compounds and methods for treating or preventing kinase-mediated disorders therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.